Cagrilintide Research Guide

This Cagrilintide Research Guide is part of the Pyrox Labs Knowledge Hub — for laboratory and research use only. Not for human or veterinary use.

WHAT IS CAGRILINTIDE?

Cagrilintide is a long-acting amylin receptor agonist, structurally related to the endogenous hormone amylin (co-secreted with insulin by pancreatic β-cells) and to the earlier amylin analogue pramlintide. A fatty-acid albumin-binding modification — the same acylation strategy used in long-acting GLP-1 compounds — extends its activity far beyond native amylin’s few-minute half-life. In research settings, cagrilintide is studied for its role in appetite-regulation pathways and its combined effects when investigated alongside GLP-1 receptor agonists. It is supplied by Pyrox Labs for laboratory and research use only. This guide summarises the published literature on cagrilintide for laboratory researchers.

RESEARCH BACKGROUND

Published literature — see this PubMed literature search — has explored areas including:

• Amylin receptor pharmacology and appetite-regulation signalling
• Monotherapy dose-finding studies in obesity/overweight research models
• Co-administration research with GLP-1 receptor agonists (semaglutide), studied under the combination designation CagriSema
• Phase 3 trial data (REDEFINE 1 and REDEFINE 2) examining weight-related and glycaemic endpoints
• Pharmacokinetic characterisation of long-acting, fatty-acid-modified peptide hormones

PROPOSED MECHANISM OF ACTION

Cagrilintide is studied as an agonist at the amylin receptor complex — a heterodimer formed from the calcitonin receptor (CTR) together with receptor activity-modifying proteins (RAMP1/RAMP3). Activation of this receptor complex, concentrated in the hindbrain (area postrema), is associated with reduced food intake in preclinical models. A 2025 mechanistic study (eBioMedicine) reported that cagrilintide’s bodyweight-related effects in research models depend specifically on amylin receptors 1 and 3 in the brain. Because its mechanism (amylin pathway) is distinct from — but complementary to — the GLP-1 receptor pathway studied with compounds such as SM1 and TZ2, cagrilintide is frequently examined in combination research protocols. It is important to note that a large proportion of the highest-profile published data (the REDEFINE programme) studies cagrilintide in fixed combination with a GLP-1 receptor agonist rather than in isolation.

CAGRILINTIDE RESEARCH GUIDE — HANDLING & STORAGE

• Store lyophilised cagrilintide vials in a freezer (-20°C), protected from light, for long-term storage.
• Once reconstituted, store refrigerated (2–8°C) and use within the timeframe indicated by your research protocol.
• Use sterile technique and appropriate PPE when handling.
• See our Reconstitution Guide for general laboratory reconstitution reference information.

CERTIFICATES OF ANALYSIS

Independently tested for purity and identity. Search by product name and the batch/lot number printed on your vial label.

VIEW COA HUB →

FREQUENTLY ASKED QUESTIONS

Is cagrilintide approved for human use?
No. Cagrilintide products sold by Pyrox Labs are not approved by any regulatory authority for human or veterinary use. They are sold strictly for laboratory and research purposes.

Can Pyrox Labs advise on dosing or administration?
No. We do not provide dosing, administration, or treatment guidance of any kind. Our team can only answer questions relating to order status, product specifications, and COA/testing documentation.

Is cagrilintide the same as a GLP-1 compound like SM1 or TZ2?
No. Cagrilintide targets the amylin receptor pathway, a distinct mechanism from the GLP-1 receptor pathway studied with SM1 (semaglutide-type) and TZ2 (tirzepatide-type) compounds. Published research has examined the two pathways in combination, but they are pharmacologically separate compounds.

How is cagrilintide supplied for laboratory research?
Pyrox Labs supplies cagrilintide as a lyophilised (freeze-dried) powder in sealed research vials, with each batch accompanied by a Certificate of Analysis confirming purity and identity.